This talk will present how quantitative systems toxicology (QST) modeling can aid in evaluating potential drug-drug interactions.
Synthesis of 1,2,3-Triazole Benzophenone Derivatives and Evaluation of in vitro Sun Protection, Antioxidant Properties, and Antiproliferative Activity on HT-144 Melanoma Cells
Benzophenones display several biological activities, including antioxidant, anticancer, and photoprotective.
First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review
FDA Review Cites DILIsym Results as Part of Turalio® Submission
Evaluation of models for predicting pediatric fraction unbound in plasma for human health risk assessment
Pediatric physiologically based pharmacokinetic (PBPK) models facilitate the prediction of PK parameters in children under specific exposure conditions.
Liothyronine could block the programmed death-ligand 1 (PDL1) activity: an e-Pharmacophore modeling and virtual screening study
The interaction between PD-L1 on tumor cells and the programmed death 1 (PD1) on immune cells helps them to escape the immune system elimination.
Permeability evaluation of gemcitabine-CPP6 conjugates in Caco-2 cells
Cancer is one of the most alarming diseases due to its high mortality and still increasing incidence rate.
Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach
At present, there is no cure or vaccine for the devastating new highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has...
Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen
In 2019, the California Office of Environmental Health Hazard Assessment (OEHHA) initiated a review of the carcinogenic hazard potential of acetaminophen.
N-alkyl isatin derivatives: Synthesis, nematicidal evaluation and protein target identifications for their mode of action
Meloidogyne incognita is an economically dominant pathogen infesting a wide range of crops curbing their growth and productivity
Mechanistic evaluation of the effect of sodium‐dependent glucose transporter 2 inhibitors on delayed glucose absorption in patients with type 2 diabetes mellitus using a quantitative systems pharmacology model of human systemic glucose dynamics
Sodium‐dependent glucose transporter (SGLT) 2 is specifically expressed in the kidney, while SGLT1 is present in the kidneys and small intestine.
What’s New in GastroPlus® v9.8
GastroPlus® version 9.8 has the most innovative & integrative software improvements to accelerate drug development through...
Simulations Plus Releases GastroPlus® Version 9.8
Pharmaceutical researchers can confirm much more than just their “gut instinct” with enhancements to all validated non-oral delivery route models
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study
Neurocysticercosis and trichuriasis are difficult-to-treat parasitic infections that affect more than 1.5 billion people worldwide. Oxfendazole...
Quantitative Prediction of Cisplatin-Induced Acute Kidney Injury Using RENAsym, a Mechanistic Quantitative Systems Toxicology Model, and Renal Proximal Tubule Epithelial Cell In vitro Assays
Nephrotoxic drugs like cisplatin cause acute kidney injury (AKI) through complex cellular mechanisms that include mitochondrial dysfunction...
Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection
A physiologically based pharmacokinetic (PBPK) human model for alpelisib, an oral α-specific class I phosphatidylinositol-3-kinase (PI3K) inhibitor...
Modified tetra-oxygenated xanthones analogues as anti-MRSA and P. aeruginosa agent and their synergism with vancomycin
Five isolated xanthones from the C. cochinchinense and G. mangostana were evaluated and tested for antibacterial activities.
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals...
Development of cardiotoxicity model using ligand-centric and receptor-centric descriptors
Bioinformatics and statistical analysis have been employed to develop a classification model to distinguish
toxic and non-toxic molecules.
What’s New in DSX™
DILIsym is quantitative systems toxicology (QST) software that integrates in vitro mechanistic data and PBPK predictions of drug concentration in the...